Structure

Physi-Chem Properties

Molecular Weight:  250.12
Volume:  252.282
LogP:  0.865
LogD:  1.035
LogS:  -1.643
# Rotatable Bonds:  0
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.516
Synthetic Accessibility Score:  4.689
Fsp3:  0.714
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.88
MDCK Permeability:  7.659124094061553e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.673
Human Intestinal Absorption (HIA):  0.041
20% Bioavailability (F20%):  0.058
30% Bioavailability (F30%):  0.007

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.744
Plasma Protein Binding (PPB):  47.05280303955078%
Volume Distribution (VD):  0.529
Pgp-substrate:  66.37427520751953%

ADMET: Metabolism

CYP1A2-inhibitor:  0.048
CYP1A2-substrate:  0.124
CYP2C19-inhibitor:  0.017
CYP2C19-substrate:  0.697
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.076
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.193
CYP3A4-inhibitor:  0.023
CYP3A4-substrate:  0.211

ADMET: Excretion

Clearance (CL):  10.783
Half-life (T1/2):  0.706

ADMET: Toxicity

hERG Blockers:  0.032
Human Hepatotoxicity (H-HT):  0.807
Drug-inuced Liver Injury (DILI):  0.385
AMES Toxicity:  0.021
Rat Oral Acute Toxicity:  0.209
Maximum Recommended Daily Dose:  0.196
Skin Sensitization:  0.05
Carcinogencity:  0.205
Eye Corrosion:  0.01
Eye Irritation:  0.039
Respiratory Toxicity:  0.201

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC51499

Natural Product ID:  NPC51499
Common Name*:   16-Epi-Scalarolbutenolide
IUPAC Name:   [(4S,5aS,5bR,7aS,11aS,11bR,13R,13aR,13bS)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-2-oxo-5,5a,6,7,7a,9,10,11,11b,12,13,13b-dodecahydro-4H-phenanthro[1,2-g][1]benzofuran-4-yl] acetate
Synonyms:   16-Epi-Scalarolbutenolide
Standard InCHIKey:  NUXDYAGOJZSDBF-ZWRXBZFVSA-N
Standard InCHI:  InChI=1S/C27H40O5/c1-15(28)31-17-13-20-26(5)11-8-18-24(2,3)9-7-10-25(18,4)19(26)14-21(29)27(20,6)23-16(17)12-22(30)32-23/h12,17-21,23,29H,7-11,13-14H2,1-6H3/t17-,18-,19+,20-,21+,23-,25-,26+,27+/m0/s1
SMILES:  CC(=O)O[C@H]1C[C@@H]2[C@]([C@@H]3C1=CC(=O)O3)(C)[C@H](O)C[C@H]1[C@@]2(C)CC[C@@H]2[C@]1(C)CCCC2(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL476919
PubChem CID:   21600071
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Red Sea n.a. PMID[11809054]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Indian Ocean n.a. PMID[16124771]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Red Sea n.a. PMID[16378375]
NPO25507 Spongia agaricina Species Spongiidae Eukaryota n.a. n.a. n.a. PMID[9548857]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[9584401]
NPO33333 hyrtios erecta Species Thorectidae Eukaryota n.a. Maldives n.a. PMID[9873492]
NPO25507 Spongia agaricina Species Spongiidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus IC50 = 5.0 ug.mL-1 PMID[519471]
NPT81 Cell Line A549 Homo sapiens IC50 = 5.0 ug.mL-1 PMID[519471]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 5.0 ug.mL-1 PMID[519471]
NPT170 Cell Line SK-MEL-28 Homo sapiens IC50 = 5.0 ug.mL-1 PMID[519471]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis Inhibition = 40.0 % PMID[519470]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC51499 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.989 High Similarity NPC275086
0.989 High Similarity NPC325229
0.914 High Similarity NPC276110
0.9072 High Similarity NPC97487
0.9072 High Similarity NPC196471
0.9072 High Similarity NPC189588
0.9072 High Similarity NPC10232
0.9072 High Similarity NPC187302
0.9072 High Similarity NPC45897
0.9032 High Similarity NPC105490
0.8925 High Similarity NPC7349
0.8913 High Similarity NPC78973
0.8889 High Similarity NPC131813
0.8866 High Similarity NPC11974
0.8866 High Similarity NPC268829
0.8866 High Similarity NPC247701
0.8866 High Similarity NPC295110
0.8866 High Similarity NPC25177
0.8866 High Similarity NPC222875
0.8854 High Similarity NPC278673
0.8817 High Similarity NPC329842
0.8812 High Similarity NPC475030
0.88 High Similarity NPC471205
0.8778 High Similarity NPC474013
0.8763 High Similarity NPC477716
0.8763 High Similarity NPC38855
0.8763 High Similarity NPC251680
0.8763 High Similarity NPC477721
0.875 High Similarity NPC477719
0.875 High Similarity NPC477718
0.87 High Similarity NPC220217
0.87 High Similarity NPC119855
0.87 High Similarity NPC51719
0.8687 High Similarity NPC281378
0.8687 High Similarity NPC160583
0.8673 High Similarity NPC477717
0.8614 High Similarity NPC473586
0.8586 High Similarity NPC475038
0.8586 High Similarity NPC165250
0.8586 High Similarity NPC476081
0.8586 High Similarity NPC109195
0.8571 High Similarity NPC161527
0.8571 High Similarity NPC477968
0.8571 High Similarity NPC228251
0.8571 High Similarity NPC474190
0.8571 High Similarity NPC20113
0.8571 High Similarity NPC324841
0.8571 High Similarity NPC477971
0.8571 High Similarity NPC477972
0.8571 High Similarity NPC219285
0.8544 High Similarity NPC177047
0.8529 High Similarity NPC475263
0.8526 High Similarity NPC472641
0.8526 High Similarity NPC472640
0.8515 High Similarity NPC186668
0.8515 High Similarity NPC88349
0.8515 High Similarity NPC471206
0.85 High Similarity NPC120321
0.85 High Similarity NPC120009
0.85 High Similarity NPC472821
0.8485 Intermediate Similarity NPC235920
0.8485 Intermediate Similarity NPC96784
0.8485 Intermediate Similarity NPC471412
0.8485 Intermediate Similarity NPC473160
0.8485 Intermediate Similarity NPC472554
0.8469 Intermediate Similarity NPC218107
0.8454 Intermediate Similarity NPC234993
0.8454 Intermediate Similarity NPC134072
0.8454 Intermediate Similarity NPC194132
0.8454 Intermediate Similarity NPC165632
0.8438 Intermediate Similarity NPC140277
0.8438 Intermediate Similarity NPC477722
0.8431 Intermediate Similarity NPC475074
0.8431 Intermediate Similarity NPC122816
0.8421 Intermediate Similarity NPC234335
0.8421 Intermediate Similarity NPC130840
0.8421 Intermediate Similarity NPC41239
0.84 Intermediate Similarity NPC258547
0.84 Intermediate Similarity NPC11956
0.84 Intermediate Similarity NPC273668
0.84 Intermediate Similarity NPC283343
0.84 Intermediate Similarity NPC472552
0.8387 Intermediate Similarity NPC166857
0.8384 Intermediate Similarity NPC476767
0.8384 Intermediate Similarity NPC471413
0.8384 Intermediate Similarity NPC16601
0.8367 Intermediate Similarity NPC476878
0.8367 Intermediate Similarity NPC476879
0.8352 Intermediate Similarity NPC311070
0.835 Intermediate Similarity NPC38948
0.835 Intermediate Similarity NPC275539
0.835 Intermediate Similarity NPC304276
0.835 Intermediate Similarity NPC189075
0.835 Intermediate Similarity NPC137462
0.8333 Intermediate Similarity NPC139692
0.8333 Intermediate Similarity NPC152778
0.8333 Intermediate Similarity NPC472812
0.8333 Intermediate Similarity NPC162615
0.8333 Intermediate Similarity NPC110022
0.8333 Intermediate Similarity NPC34768
0.8333 Intermediate Similarity NPC53555
0.8333 Intermediate Similarity NPC205034
0.8317 Intermediate Similarity NPC23584
0.8317 Intermediate Similarity NPC478057
0.8317 Intermediate Similarity NPC112009
0.8317 Intermediate Similarity NPC474822
0.8317 Intermediate Similarity NPC471938
0.8316 Intermediate Similarity NPC472642
0.8316 Intermediate Similarity NPC221111
0.8316 Intermediate Similarity NPC280149
0.8302 Intermediate Similarity NPC171126
0.83 Intermediate Similarity NPC475617
0.8298 Intermediate Similarity NPC93411
0.8298 Intermediate Similarity NPC106332
0.8283 Intermediate Similarity NPC477876
0.8283 Intermediate Similarity NPC477875
0.828 Intermediate Similarity NPC471219
0.8269 Intermediate Similarity NPC476759
0.8269 Intermediate Similarity NPC206618
0.8265 Intermediate Similarity NPC475380
0.8265 Intermediate Similarity NPC209297
0.8265 Intermediate Similarity NPC16967
0.8261 Intermediate Similarity NPC32223
0.8261 Intermediate Similarity NPC299963
0.8261 Intermediate Similarity NPC102048
0.8252 Intermediate Similarity NPC110496
0.8252 Intermediate Similarity NPC67321
0.8252 Intermediate Similarity NPC179380
0.8252 Intermediate Similarity NPC187435
0.8252 Intermediate Similarity NPC302788
0.8247 Intermediate Similarity NPC3359
0.8247 Intermediate Similarity NPC469697
0.8247 Intermediate Similarity NPC57117
0.8247 Intermediate Similarity NPC91010
0.8247 Intermediate Similarity NPC201725
0.8241 Intermediate Similarity NPC474418
0.8241 Intermediate Similarity NPC84987
0.8241 Intermediate Similarity NPC99728
0.8241 Intermediate Similarity NPC157376
0.8241 Intermediate Similarity NPC471355
0.8241 Intermediate Similarity NPC196429
0.8241 Intermediate Similarity NPC473852
0.8241 Intermediate Similarity NPC471354
0.8241 Intermediate Similarity NPC244402
0.8241 Intermediate Similarity NPC471351
0.8241 Intermediate Similarity NPC243196
0.8241 Intermediate Similarity NPC50305
0.8241 Intermediate Similarity NPC471353
0.8241 Intermediate Similarity NPC27507
0.8241 Intermediate Similarity NPC142066
0.8241 Intermediate Similarity NPC309034
0.8241 Intermediate Similarity NPC77319
0.8241 Intermediate Similarity NPC34390
0.8241 Intermediate Similarity NPC158344
0.8241 Intermediate Similarity NPC87250
0.8235 Intermediate Similarity NPC471937
0.8229 Intermediate Similarity NPC72845
0.8229 Intermediate Similarity NPC477574
0.8229 Intermediate Similarity NPC472811
0.8224 Intermediate Similarity NPC69576
0.8224 Intermediate Similarity NPC471633
0.8224 Intermediate Similarity NPC31354
0.8224 Intermediate Similarity NPC84949
0.8222 Intermediate Similarity NPC469802
0.8218 Intermediate Similarity NPC162973
0.8218 Intermediate Similarity NPC476890
0.8218 Intermediate Similarity NPC475344
0.8218 Intermediate Similarity NPC472815
0.8218 Intermediate Similarity NPC471914
0.8218 Intermediate Similarity NPC476769
0.8218 Intermediate Similarity NPC476471
0.8211 Intermediate Similarity NPC314727
0.8211 Intermediate Similarity NPC170633
0.8211 Intermediate Similarity NPC261320
0.8211 Intermediate Similarity NPC246028
0.8208 Intermediate Similarity NPC4573
0.8208 Intermediate Similarity NPC470063
0.8208 Intermediate Similarity NPC44537
0.82 Intermediate Similarity NPC117685
0.82 Intermediate Similarity NPC201406
0.82 Intermediate Similarity NPC254567
0.82 Intermediate Similarity NPC47024
0.82 Intermediate Similarity NPC474571
0.8191 Intermediate Similarity NPC471796
0.819 Intermediate Similarity NPC12795
0.819 Intermediate Similarity NPC103491
0.8182 Intermediate Similarity NPC311241
0.8182 Intermediate Similarity NPC224356
0.8182 Intermediate Similarity NPC132753
0.8182 Intermediate Similarity NPC100912
0.8182 Intermediate Similarity NPC97867
0.8182 Intermediate Similarity NPC475446
0.8182 Intermediate Similarity NPC121402
0.8182 Intermediate Similarity NPC175351
0.8182 Intermediate Similarity NPC231751
0.8182 Intermediate Similarity NPC151681
0.8173 Intermediate Similarity NPC325054
0.8173 Intermediate Similarity NPC476765
0.8173 Intermediate Similarity NPC50124
0.8173 Intermediate Similarity NPC306265

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC51499 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8854 High Similarity NPD7638 Approved
0.8763 High Similarity NPD7639 Approved
0.8763 High Similarity NPD7640 Approved
0.8165 Intermediate Similarity NPD7327 Approved
0.8165 Intermediate Similarity NPD7328 Approved
0.8091 Intermediate Similarity NPD7516 Approved
0.8039 Intermediate Similarity NPD7632 Discontinued
0.7946 Intermediate Similarity NPD8335 Approved
0.7946 Intermediate Similarity NPD8380 Approved
0.7946 Intermediate Similarity NPD8379 Approved
0.7946 Intermediate Similarity NPD8296 Approved
0.7946 Intermediate Similarity NPD8378 Approved
0.7879 Intermediate Similarity NPD7748 Approved
0.7857 Intermediate Similarity NPD8294 Approved
0.7857 Intermediate Similarity NPD7515 Phase 2
0.7857 Intermediate Similarity NPD8377 Approved
0.7788 Intermediate Similarity NPD8033 Approved
0.7757 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7745 Intermediate Similarity NPD4225 Approved
0.7717 Intermediate Similarity NPD7645 Phase 2
0.7664 Intermediate Similarity NPD6686 Approved
0.7647 Intermediate Similarity NPD7902 Approved
0.7523 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7521 Intermediate Similarity NPD7507 Approved
0.7479 Intermediate Similarity NPD7319 Approved
0.7429 Intermediate Similarity NPD5344 Discontinued
0.7353 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD7900 Approved
0.7328 Intermediate Similarity NPD7503 Approved
0.7292 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7281 Intermediate Similarity NPD7115 Discovery
0.7263 Intermediate Similarity NPD7525 Registered
0.7248 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7245 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD6648 Approved
0.7157 Intermediate Similarity NPD7637 Suspended
0.7157 Intermediate Similarity NPD8035 Phase 2
0.7157 Intermediate Similarity NPD8034 Phase 2
0.7156 Intermediate Similarity NPD7128 Approved
0.7156 Intermediate Similarity NPD5739 Approved
0.7156 Intermediate Similarity NPD6675 Approved
0.7156 Intermediate Similarity NPD6402 Approved
0.7143 Intermediate Similarity NPD6400 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD6051 Approved
0.7041 Intermediate Similarity NPD6695 Phase 3
0.703 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD6881 Approved
0.7027 Intermediate Similarity NPD7320 Approved
0.7027 Intermediate Similarity NPD6899 Approved
0.7 Intermediate Similarity NPD3618 Phase 1
0.6981 Remote Similarity NPD6084 Phase 2
0.6981 Remote Similarity NPD6083 Phase 2
0.697 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6372 Approved
0.6964 Remote Similarity NPD6373 Approved
0.6961 Remote Similarity NPD5328 Approved
0.6937 Remote Similarity NPD6412 Phase 2
0.6937 Remote Similarity NPD5701 Approved
0.6937 Remote Similarity NPD5697 Approved
0.6923 Remote Similarity NPD6399 Phase 3
0.6917 Remote Similarity NPD8328 Phase 3
0.6903 Remote Similarity NPD7290 Approved
0.6903 Remote Similarity NPD7102 Approved
0.6903 Remote Similarity NPD6883 Approved
0.6875 Remote Similarity NPD5345 Clinical (unspecified phase)
0.687 Remote Similarity NPD8133 Approved
0.6842 Remote Similarity NPD6650 Approved
0.6842 Remote Similarity NPD6869 Approved
0.6842 Remote Similarity NPD6649 Approved
0.6842 Remote Similarity NPD6847 Approved
0.6842 Remote Similarity NPD8130 Phase 1
0.6842 Remote Similarity NPD6617 Approved
0.6832 Remote Similarity NPD6684 Approved
0.6832 Remote Similarity NPD7334 Approved
0.6832 Remote Similarity NPD6409 Approved
0.6832 Remote Similarity NPD7521 Approved
0.6832 Remote Similarity NPD7146 Approved
0.6832 Remote Similarity NPD5330 Approved
0.6827 Remote Similarity NPD6079 Approved
0.6814 Remote Similarity NPD6014 Approved
0.6814 Remote Similarity NPD6013 Approved
0.6814 Remote Similarity NPD6012 Approved
0.6804 Remote Similarity NPD6929 Approved
0.6783 Remote Similarity NPD8297 Approved
0.6783 Remote Similarity NPD6882 Approved
0.6783 Remote Similarity NPD6053 Discontinued
0.6765 Remote Similarity NPD7750 Discontinued
0.6765 Remote Similarity NPD7524 Approved
0.6737 Remote Similarity NPD6942 Approved
0.6737 Remote Similarity NPD7339 Approved
0.6735 Remote Similarity NPD6930 Phase 2
0.6735 Remote Similarity NPD6931 Approved
0.6733 Remote Similarity NPD1694 Approved
0.6731 Remote Similarity NPD6698 Approved
0.6731 Remote Similarity NPD7838 Discovery
0.6731 Remote Similarity NPD46 Approved
0.6726 Remote Similarity NPD6011 Approved
0.6724 Remote Similarity NPD4632 Approved
0.6699 Remote Similarity NPD6903 Approved
0.6699 Remote Similarity NPD5737 Approved
0.6699 Remote Similarity NPD6672 Approved
0.6696 Remote Similarity NPD6008 Approved
0.6696 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6694 Remote Similarity NPD7736 Approved
0.6667 Remote Similarity NPD4755 Approved
0.6667 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6319 Approved
0.6667 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6636 Remote Similarity NPD5695 Phase 3
0.6634 Remote Similarity NPD4786 Approved
0.6634 Remote Similarity NPD3665 Phase 1
0.6634 Remote Similarity NPD3666 Approved
0.6634 Remote Similarity NPD3133 Approved
0.6606 Remote Similarity NPD5696 Approved
0.6604 Remote Similarity NPD5778 Approved
0.6604 Remote Similarity NPD5779 Approved
0.6604 Remote Similarity NPD4202 Approved
0.6602 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6602 Remote Similarity NPD3573 Approved
0.66 Remote Similarity NPD3667 Approved
0.6598 Remote Similarity NPD5776 Phase 2
0.6598 Remote Similarity NPD6925 Approved
0.6585 Remote Similarity NPD7492 Approved
0.6577 Remote Similarity NPD5211 Phase 2
0.6574 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6574 Remote Similarity NPD5222 Approved
0.6574 Remote Similarity NPD4697 Phase 3
0.6574 Remote Similarity NPD5221 Approved
0.6566 Remote Similarity NPD7514 Phase 3
0.6566 Remote Similarity NPD7332 Phase 2
0.6555 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6555 Remote Similarity NPD6009 Approved
0.6545 Remote Similarity NPD4700 Approved
0.6545 Remote Similarity NPD4696 Approved
0.6545 Remote Similarity NPD5285 Approved
0.6545 Remote Similarity NPD5286 Approved
0.6532 Remote Similarity NPD6616 Approved
0.6531 Remote Similarity NPD6697 Approved
0.6531 Remote Similarity NPD6118 Approved
0.6531 Remote Similarity NPD6115 Approved
0.6531 Remote Similarity NPD6114 Approved
0.6531 Remote Similarity NPD7145 Approved
0.6529 Remote Similarity NPD6059 Approved
0.6529 Remote Similarity NPD6054 Approved
0.6514 Remote Similarity NPD5173 Approved
0.6509 Remote Similarity NPD7087 Discontinued
0.6509 Remote Similarity NPD5693 Phase 1
0.6509 Remote Similarity NPD6411 Approved
0.6504 Remote Similarity NPD7604 Phase 2
0.65 Remote Similarity NPD6902 Approved
0.6481 Remote Similarity NPD6356 Clinical (unspecified phase)
0.648 Remote Similarity NPD7078 Approved
0.648 Remote Similarity NPD8293 Discontinued
0.6476 Remote Similarity NPD4753 Phase 2
0.6476 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6475 Remote Similarity NPD5983 Phase 2
0.6471 Remote Similarity NPD6274 Approved
0.6471 Remote Similarity NPD6868 Approved
0.646 Remote Similarity NPD5141 Approved
0.6446 Remote Similarity NPD7101 Approved
0.6446 Remote Similarity NPD7100 Approved
0.6429 Remote Similarity NPD5226 Approved
0.6429 Remote Similarity NPD6932 Approved
0.6429 Remote Similarity NPD5224 Approved
0.6429 Remote Similarity NPD5225 Approved
0.6429 Remote Similarity NPD4633 Approved
0.6423 Remote Similarity NPD6370 Approved
0.6408 Remote Similarity NPD6893 Approved
0.64 Remote Similarity NPD6336 Discontinued
0.6372 Remote Similarity NPD5174 Approved
0.6372 Remote Similarity NPD5175 Approved
0.6364 Remote Similarity NPD6335 Approved
0.635 Remote Similarity NPD7625 Phase 1
0.6341 Remote Similarity NPD6909 Approved
0.6341 Remote Similarity NPD6908 Approved
0.6341 Remote Similarity NPD6015 Approved
0.6341 Remote Similarity NPD6016 Approved
0.6339 Remote Similarity NPD5223 Approved
0.6339 Remote Similarity NPD4159 Approved
0.6337 Remote Similarity NPD6898 Phase 1
0.6327 Remote Similarity NPD6117 Approved
0.6325 Remote Similarity NPD4634 Approved
0.6325 Remote Similarity NPD6371 Approved
0.6321 Remote Similarity NPD6101 Approved
0.6321 Remote Similarity NPD6080 Approved
0.6321 Remote Similarity NPD6673 Approved
0.6321 Remote Similarity NPD6904 Approved
0.6321 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6306 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6306 Remote Similarity NPD5290 Discontinued
0.63 Remote Similarity NPD6683 Phase 2
0.63 Remote Similarity NPD4195 Approved
0.629 Remote Similarity NPD5988 Approved
0.6289 Remote Similarity NPD6924 Approved
0.6289 Remote Similarity NPD6926 Approved
0.6281 Remote Similarity NPD6317 Approved
0.6263 Remote Similarity NPD6116 Phase 1
0.6262 Remote Similarity NPD5785 Approved
0.6261 Remote Similarity NPD4767 Approved
0.6261 Remote Similarity NPD4768 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data